CN108060121B - 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 - Google Patents
小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 Download PDFInfo
- Publication number
- CN108060121B CN108060121B CN201610975762.2A CN201610975762A CN108060121B CN 108060121 B CN108060121 B CN 108060121B CN 201610975762 A CN201610975762 A CN 201610975762A CN 108060121 B CN108060121 B CN 108060121B
- Authority
- CN
- China
- Prior art keywords
- small molecule
- vpa
- cells
- chir99021
- forskolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/71—Oxidoreductases (EC 1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/09—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975762.2A CN108060121B (zh) | 2016-11-07 | 2016-11-07 | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975762.2A CN108060121B (zh) | 2016-11-07 | 2016-11-07 | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108060121A CN108060121A (zh) | 2018-05-22 |
CN108060121B true CN108060121B (zh) | 2021-05-28 |
Family
ID=62136779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610975762.2A Active CN108060121B (zh) | 2016-11-07 | 2016-11-07 | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108060121B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117887659A (zh) * | 2018-05-01 | 2024-04-16 | 云南济慈再生医学研究院有限公司 | 一种促进靶细胞向神经细胞分化的方法 |
CN108588016A (zh) * | 2018-05-14 | 2018-09-28 | 王帅 | 由牙髓干细胞向牙齿骨细胞分化的方法和组合物及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014146039A2 (en) * | 2013-03-15 | 2014-09-18 | Human Biomolecular Research Institute | Compounds and matrices for use in bone growth and repair |
CN104762324B (zh) * | 2015-03-06 | 2017-12-15 | 昆明学院 | 利用Runx2和小分子化合物诱导人成纤维细胞重编程为成骨细胞的方法 |
TW201819625A (zh) * | 2016-08-23 | 2018-06-01 | 中央研究院 | 製備誘導型間質幹細胞及增進間質幹細胞之特質的方法及其應用 |
-
2016
- 2016-11-07 CN CN201610975762.2A patent/CN108060121B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108060121A (zh) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108060120B (zh) | 用于分化的细胞重编程的小分子化合物组合、试剂盒及应用 | |
Grath et al. | Direct cell reprogramming for tissue engineering and regenerative medicine | |
Isomi et al. | Progress and challenge of cardiac regeneration to treat heart failure | |
Kadar et al. | Differentiation potential of stem cells from human dental origin-promise for tissue engineering | |
CN108060119B (zh) | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备血管平滑肌细胞的方法 | |
Tabar et al. | Pluripotent stem cells in regenerative medicine: challenges and recent progress | |
Meyer et al. | Restorative approaches in Parkinson's Disease: which cell type wins the race? | |
Hopf et al. | Schwann cell-like cells: origin and usability for repair and regeneration of the peripheral and central nervous system | |
Torper et al. | Brain repair from intrinsic cell sources: Turning reactive glia into neurons | |
CN108060123B (zh) | 一种用于体细胞去分化的靶点调控系统、试剂盒及应用 | |
Uz et al. | Advances in controlling differentiation of adult stem cells for peripheral nerve regeneration | |
CN104894060A (zh) | 诱导体细胞转分化为神经干细胞的方法及其应用 | |
CN108060126B (zh) | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 | |
CN108070549A (zh) | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备血管内皮细胞的方法 | |
Liao et al. | Direct conversion of cord blood CD34+ cells into neural stem cells by OCT4 | |
AU2016264166A1 (en) | Method for inducing oligodendrocyte precursor cells from Oct4-induced human somatic cells through direct reprogramming | |
CN108060121B (zh) | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备成骨细胞的方法 | |
KR20100003141A (ko) | 셀레늄에 의해 탈분화된 세포, 이의 제조방법 및 이의 용도 | |
Dai et al. | The Human Skin‐Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives | |
WO2018130178A1 (zh) | 用于预防、延缓或逆转细胞、组织、器官、机体衰老的小分子化合物/组合,产品及其用途 | |
Kumar et al. | Dopaminergic-primed fetal liver mesenchymal stromal–like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice | |
CN108060122B (zh) | 小分子化合物组合及利用该小分子化合物组合诱导分化的细胞制备软骨细胞的方法 | |
CN107429233B (zh) | 神经系统细胞的制造方法 | |
Ebrahimi | Reprogramming of adult stem/progenitor cells into iPSCs without reprogramming factors | |
Fu et al. | Potential replication of induced pluripotent stem cells for craniofacial reconstruction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210408 Address after: 516211 No.301, 3rd floor, qiaoshengyayuan, Danshui Renmin Road, Huiyang District, Huizhou City, Guangdong Province Applicant after: Huizhou Zhengduo Industrial Co.,Ltd. Address before: 650217 No.2 Puxin Road, Kunming Economic and Technological Development Zone, Yunnan Province Applicant before: KUNMING University Applicant before: YUNNAN PROVINCIAL ACADEMY OF SCIENCE AND TECHNOLOGY |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210709 Address after: 518000 328, 3rd floor, phase I, comprehensive Xinxing, No.1 Haihong Road, Fubao community, Fubao street, Futian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Zhende Keats pharmaceutical research and Development Co.,Ltd. Address before: 516211 No.301, 3rd floor, qiaoshengyayuan, Danshui Renmin Road, Huiyang District, Huizhou City, Guangdong Province Patentee before: Huizhou Zhengduo Industrial Co.,Ltd. |
|
TR01 | Transfer of patent right |